Advanced search
Publication Cover
Journal of Asthma Volume 61, 2024 - Issue 4
Submit an article Journal homepage
1,038
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study

Jinping Zhenga State Key Lab of Respiratory Disease, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaView further author information
, MD,
Jianyong Zhangb Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
, MD,
Xiuhua Fuc Respiratory Department, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, ChinaView further author information
, MD,
Changqing Lind Department of Respiratory Medicine, Huizhou Central People’s Hospital, Huizhou, ChinaView further author information
, MD,
Xinri Zhange NHC Key Laboratory of Pneumoconiosis, Shanxi Key Laboratory of Respiratory Diseases, The First Hospital of Shanxi Medical University, Taiyuan, ChinaView further author information
, MD,
Xiaodong Meif Department of Respiratory and Critical Care Medicine, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, ChinaView further author information
, MD,
Massimo Corradig Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
, MD,
Glauco Cappellinih Global Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyView further author information
, MSc,
Emanuele Calabroh Global Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyView further author information
, MSc,
Cissy Zhui Global Clinical Development, Chiesi Pharmaceutical Consulting (Shanghai) Co. Ltd, Shanghai, ChinaView further author information
, BSc, BA &
Eva Topoleh Global Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyCorrespondence[email protected]
View further author information
, MD show all
Pages 360-367 | Received 28 Jul 2023, Accepted 15 Oct 2023, Published online: 01 Nov 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.